Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages

Natalie E Nieuwenhuizen1, Frank Kirstein, Jaisubash Jayakumar

  • 1International Center for Genetic Engineering and Biotechnology, Cape Town, South Africa.

Abstract

Insights

Alternatively activated macrophages (AAMs) are associated with allergic airway disease but do not drive its pathology. Genetic ablation of IL-4Rα in macrophages did not alter disease severity, suggesting AAMs are not key players.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Cell Biology

Background:

  • Alternatively activated macrophages (AAMs) are implicated in allergic airway diseases like asthma.
  • AAMs are hypothesized to worsen disease through reduced nitric oxide and increased collagen synthesis.

Purpose of the Study:

  • To investigate the functional role of AAMs in the pathogenesis of allergic airway disease.
  • To determine if impairing AAM activation affects disease development and severity.

Main Methods:

  • Utilized LysM(cre)IL-4Rα(-/lox) mice with genetically abrogated IL-4 receptor alpha (IL-4Rα) in macrophages.
  • Examined responses in ovalbumin- and house dust mite-induced allergic airway disease models.
  • Assessed airway hyperreactivity, inflammatory cell infiltration, mucus production, and collagen deposition.

Main Results:

  • Depletion of IL-4Rα in macrophages reduced AAM markers but did not significantly decrease airway hyperreactivity, T(H)2 responses, mucus, eosinophils, or collagen.
  • Both genetically modified mice and controls exhibited similar disease severity in acute and chronic models.
  • No significant difference in disease outcomes was observed between LysM(cre)IL-4Rα(-/lox) mice and controls.

Conclusions:

  • The presence of AAMs in allergic airway disease may be correlational rather than causal.
  • IL-4Rα-dependent AAMs do not appear to play a critical role in the pathology of allergic airway disease.
  • Findings suggest AAMs are a consequence of, not a driver of, disease pathogenesis.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112